REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 69 filers reported holding REGENXBIO INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $3,950,000 | -49.5% | 200,000 | -50.6% | 0.17% | -46.1% |
| Q1 2017 | $7,820,000 | +29.6% | 405,204 | +24.6% | 0.31% | +5.8% |
| Q4 2016 | $6,033,000 | +41.2% | 325,204 | +6.6% | 0.29% | +11.0% |
| Q3 2016 | $4,273,000 | +63.1% | 305,000 | -6.9% | 0.26% | +30.0% |
| Q2 2016 | $2,620,000 | -29.7% | 327,559 | -5.1% | 0.20% | +25.3% |
| Q1 2016 | $3,726,000 | -33.3% | 345,000 | +2.5% | 0.16% | -57.9% |
| Q4 2015 | $5,585,000 | -7.5% | 336,474 | +22.8% | 0.38% | +44.2% |
| Q3 2015 | $6,036,000 | – | 273,974 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 839,139 | $35,177,000 | 6.39% |
| Sonic Fund II, L.P. | 188,786 | $7,914,000 | 4.47% |
| ArchPoint Investors | 297,355 | $12,465,000 | 3.73% |
| Redmile Group, LLC | 2,008,001 | $84,175,000 | 1.47% |
| RTW INVESTMENTS, LP | 1,845,366 | $77,358,000 | 1.17% |
| WS MANAGEMENT LLLP | 210,729 | $8,834,000 | 0.94% |
| FRAZIER MANAGEMENT LLC | 235,809 | $9,885,000 | 0.79% |
| Integral Health Asset Management, LLC | 55,000 | $2,306,000 | 0.66% |
| Sofinnova Investments, Inc. | 127,593 | $5,349,000 | 0.32% |
| HHLR ADVISORS, LTD. | 456,000 | $19,116,000 | 0.25% |